Pre-earnings options volume in Regencell Bioscience (RGC) Holdings Ltd is 1.1x normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 42.1%, or 0c, after results are released. Median move over the past eight quarters is 14.3%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGC:
- What Triggered the Wild 120% Rally in Regencell Bioscience Stock (RGC)?
- Regencell Bioscience Holdings Ltd trading resumes
- Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
- Six new option listings and two option delistings on July 1st
- Regencell Bioscience Reports Improved Financial Results for First Half of 2025